Intrinsiqq
Demant A/S logo

Demant A/S (DEMANT.XCSE) DCF Valuation

Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.

Conservative

kr 90.39

74% overvaluedvs kr 352.30

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Base

kr 111.33

68% overvaluedvs kr 352.30

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Optimistic

kr 134.30

62% overvaluedvs kr 352.30

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Where today's price sits

Today kr 352.30
Conservative kr 90.39
Base kr 111.33
Optimistic kr 134.30

Today's price falls outside the modelled range.

Verdict

Today's price sits above all three scenarios. Under these assumptions the stock looks overvalued, so either the growth inputs are too conservative or the price is ahead of the cash flows.

Base free cash flow

kr 3.00B

Trailing twelve months

Historical FCF CAGR

+0.9%

Across 6 reported periods

Market implies

12.3%

Growth needed at 8% WACC

Terminal value share

58%

Of the base case valuation

Growth needed to justify today's price

At a 8.0% discount rate, today's price already assumes 12.3% annual free cash flow growth for ten years. Your base case assumes 2.0%, so the market is paying for growth you are not forecasting.

Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.

Free cash flow history

The most recent period is the base every projection starts from. Compounded, that history is +0.9% a year.

Source: company annual reportsLast synced Jun 16, 2026Base FCF kr 3.00B (TTM)

A DCF output is an assumption-sensitive range, not a price target. This model is an algorithmic estimate from your inputs and company filings, and it is not a recommendation to buy, sell or hold. Terms · Methodology

Demant A/S (DEMANT.XCSE) DCF: intrinsic value and margin of safety

Intrinsiqq's two-stage DCF values Demant A/S (DEMANT.XCSE) at about DKK 148.44 per share, or DKK 111.33 with a 25% margin of safety. At DKK 352.30 the stock looks overvalued. Every assumption is adjustable below; this is analysis, not investment advice.

Frequently asked

What is Demant A/S's (DEMANT.XCSE) fair value?+

Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about DKK 148.44 per share for DEMANT.XCSE. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around DKK 111.33. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.

Is Demant A/S overvalued based on a DCF?+

At DKK 352.30, DEMANT.XCSE trades above the base-case intrinsic value of about DKK 148.44, a 57.9% premium over that estimate, so on this model it looks overvalued. A DCF is only one lens: a premium can be justified if the business grows faster or is higher quality than the base case assumes, which is exactly what the sliders let you test.

What growth is priced into Demant A/S?+

The base case grows DEMANT.XCSE's free cash flow at about 2.0% a year before fading, against roughly 0.9% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.

What is a good margin of safety for Demant A/S?+

A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns DEMANT.XCSE's DKK 148.44 intrinsic estimate into a DKK 111.33 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Medical Devices

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.